Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give written consent before any study procedures begin, following the guidelines of the institution running the trial
- Women aged 18 or older
- People whose general health and ability to carry out daily activities falls within a certain range, as measured by a standard cancer performance scale (scores 0 to 2, where 0 means fully active and 2 means up and about more than half of the day)
- People who have a confirmed diagnosis of triple-negative breast cancer (TNBC) that has spread to other parts of the body and is getting worse, with measurable disease visible on specific scans — either a PET/CT scan done within 2 weeks before the PSMA scan, or a brain MRI done within 4 weeks before the PSMA scan if the cancer has spread to the brain
- People who have had a specialised PSMA PET/CT scan completed before starting their next round of cancer treatment
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who have another active cancer diagnosis at the same time
- People who have received another experimental treatment or investigational drug within the past 30 days
- People whose cancer has spread only to the skin
- People with a serious medical, mental health, or surgical condition that, in the opinion of the treating doctor, could interfere with completing the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 025413095
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess PSMA expression in progressive metastatic TNBC patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.